APA

Raber A., Heras J., Costa J., Fortea J. & Cobos A. (20110714). Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom. : Therapeutics and clinical risk management.

Chicago

Raber Anna, Heras Joan, Costa Joan, Fortea Josep and Cobos Albert. 20110714. Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom. : Therapeutics and clinical risk management.

Harvard

Raber A., Heras J., Costa J., Fortea J. and Cobos A. (20110714). Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom. : Therapeutics and clinical risk management.

MLA

Raber Anna, Heras Joan, Costa Joan, Fortea Josep and Cobos Albert. Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom. : Therapeutics and clinical risk management. 20110714.